Tenaya Therapeutics, Inc.

TNYA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
83
SEC Filings

Business Summary

. Overview We are a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver potentially curative therapies that address the underlying drivers of heart disease. Heart disease remains the leading cause of death in the world. In the U.S., one person dies from a cardiovascular-related health condition every 34 seconds, a gruesome statistic that translates to one in every three deaths in the U.S each year. One in 20 adults suffer from congenital heart disea...

Next Earnings

Q2 FY2026 — expected 2026-08-05

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTNYAdiscussed_in_filing Cybersecurity
topic_mentionTNYAdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-112025-12-310001193125-26-102252EDGAR95K words
2025-03-102024-12-310000950170-25-036329EDGAR—
2024-03-182023-12-310000950170-24-032828EDGAR—
2023-03-082022-12-310000950170-23-006725EDGAR—
2022-03-232021-12-310000950170-22-004426EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-273239EDGAR61K words
2025-08-062025-06-300000950170-25-104182EDGAR—
2025-05-072025-03-310000950170-25-065741EDGAR—
2024-11-062024-09-300000950170-24-122359EDGAR—
2024-08-082024-06-300000950170-24-094059EDGAR—
2024-05-142024-03-310000950170-24-059576EDGAR—
2023-11-082023-09-300000950170-23-061162EDGAR—
2023-08-092023-06-300000950170-23-040651EDGAR—
2023-05-102023-03-310000950170-23-020609EDGAR—
2022-11-102022-09-300000950170-22-024521EDGAR—
2022-08-102022-06-300000950170-22-016478EDGAR—
2022-05-112022-03-310000950170-22-009363EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-110001193125-26-102170EDGAR3K words
2026-03-050001193125-26-092654EDGAR—
2026-01-300001193125-26-032017EDGAR—
2026-01-020001193125-26-001065EDGAR—
2025-12-120001193125-25-317642EDGAR—
2025-12-110001193125-25-315951EDGAR—
2025-11-100001193125-25-273230EDGAR—
2025-11-070001193125-25-272423EDGAR—
2025-08-060000950170-25-104164EDGAR—
2025-05-300000950170-25-079773EDGAR—

83 total filings indexed. 56 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001858848
TickerTNYA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8f559adeeec4bdb0edb0865d463b08207c926bbf12d92c7cdc7efd1e53a02f45
parent: 2e9b02abb7d86d55e424ae405b455e5d8b228fa6750c5374174997d6f3dc5161
content hash: d5cf784c0f4a0d8610619f0fe92e5b9a4835539607baf83168187fed37dc5222
signed: 2026-04-13T04:47:50.513Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf